• FirefoxUpgrade to the new Firefox »
  •  Dow Up0.15% Nasdaq Up0.36%

    Isis Pharmaceuticals, Inc. (ISIS)

    -NasdaqGS
    65.09 5.54(9.30%) Dec 19, 4:00PM EST
    |Pre-Market : 63.82 Down 1.27 (1.95%) 8:54AM EST - Nasdaq Real Time Price
    Add to Portfolio
    Analyst OpinionGet Analyst Opinion for:
    Recommendation Summary*
    Mean Recommendation (this week):2.5
    Mean Recommendation (last week):2.5
    Change:0.0

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Price Target Summary
    Mean Target:55.90
    Median Target:63.00
    High Target:81.00
    Low Target:10.00
    No. of Brokers:10

    Data provided by Thomson/First Call

    Upgrades & Downgrades History
    DateResearch FirmActionFromTo
    Oct 17, 2012Summer Street ResearchDowngradeBuyNeutral
    May 22, 2012NeedhamInitiated Buy
    Mar 26, 2012Canaccord GenuityInitiated Hold
    Aug 5, 2010MP AdvisorsDowngradeOutperformMarket Perform
    Aug 5, 2010Collins StewartDowngradeBuyHold
    Apr 6, 2010Auriga U.S.AInitiated Hold
    Jul 29, 2009Cantor FitzgeraldInitiated Buy
    Feb 10, 2009CitigroupInitiated Hold
    Jan 9, 2009Morgan JosephInitiated Buy
    Dec 16, 2008Collins StewartInitiated Buy

    More Upgrades & Downgrades for ISIS

    Data provided by Briefing.com - Take a free trial
    Complete Live market analysis of the U.S. stock and bond markets, technology stocks, economic releases, earnings reports, and day trading highlights.

    Recommendation Trends
    Current MonthLast MonthTwo Months AgoThree Months Ago
    Strong Buy0111
    Buy0666
    Hold0333
    Underperform0000
    Sell0111

    Data provided by Thomson/First Call


    Currency in USD.